Tadalafil Articles
Stock Commentary - New York
29 March 2004
Lilly's Cialis bites into Viagra's market share
29 March 2004
Ranbaxy launches Forzest in India for ED
22 March 2004
New data for Bayer/GSK's Levitra
8 March 2004
Lilly ICOS' Cialis gets EU label change
1 March 2004
Strong 2003 sales for Lilly but profits flat
9 February 2004
Lilly ICOS Cialis sales exceed $200M
2 February 2004
Stock Commentary - New York
2 February 2004
New US Cialis ad to debut at Super Bowl
2 February 2004
New Chemical Entities in 2003
19 January 2004
Stock Commentary - New York
15 December 2003
Stock Commentary - New York
3 November 2003
Launches hit Lilly's profits, sales strong
27 October 2003
Impotence drugs selling fast in South Korea
27 October 2003
Stock Commentary - New York
8 September 2003
Cellegy issued patent for female sexual dysfunction therapy method
8 September 2003
Zyprexa lifts Eli Lilly above estimates
4 August 2003
ICOS note purchasers exercise $28.6M option
21 July 2003
Lilly to launch new drugs in Hungary
21 July 2003
Cialis still on track for US approval
7 July 2003
ICOS to offer $250M convertible subordinated notes
23 June 2003
Bayer/GSK's Levitra closer to US approval
9 June 2003
Cialis on track for US approval in 2H
12 May 2003
Stock Commentary - New York
21 April 2003
Bayer/GSK's Levitra cleared in Europe
17 March 2003
Pfizer merger oked by EC but not without cost
10 March 2003
Lilly takes sepsis, ED drugs into Phase II in Japan
3 March 2003
Singapore first Asian market for Cialis
24 February 2003
2002's crop of new product launches backs up R&D fears
10 February 2003
ICOS doubles its losses in 2002, revenues flat
10 February 2003
Lilly ICOS' Cialis rolls out in first markets
10 February 2003
UK first country for Cialis launch?
3 February 2003
Stock Commentary - New York
19 August 2002
Stock Commentary - New York
5 August 2002
S-P pulls out of alliance with Zonagen on ED
22 July 2002
UK court rules against Viagra patent
24 June 2002
Stock Commentary - New York
10 June 2002
New data on Viagra rivals presented
3 June 2002
Stock Commentary - New York
13 May 2002
ICOS reports further losses
29 April 2002
UK court rejects Pfizer appeal on PDE patent
28 January 2002
Lilly and FDA talking about plant problems
7 January 2002
Lilly and FDA talking about plant problems
19 December 2001
Chugai Lilly Research to be disbanded
10 December 2001
Bayer reports heavy loss as impact of Baycol withdrawal takes hold
15 November 2001
Xigris still on track for US approval?
23 October 2001
Stock Commentary - New York
11 October 2001
New data on Viagra's looming competitors
4 October 2001
Bayer files for approval of ED drug in USA
26 September 2001
Bayer files for approval of ED drug in USA
25 September 2001
Lilly ICOS' Cialis NDA accepted by FDA
3 September 2001
New drugs lift Lilly's 2nd qtr sales 16%
23 July 2001
Cialis filed in Europe
12 July 2001
Lilly ICOS asks for FDA OK for Cialis
29 June 2001
Lilly ICOS' Cialis shows little effect in women
18 June 2001
Cialis offers 24-hour activity in impotence
2 May 2001
Lilly's Zovant fast-tracked in USA
30 March 2001
Cialis shows mettle as Viagra rival
20 March 2001
Eli Lilly's once-weekly Prozac gains approval from US FDA
28 February 2001
Pfizer loses Viagra patent in UK
9 November 2000
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
